InvestorsHub Logo
Followers 416
Posts 34739
Boards Moderated 1
Alias Born 08/22/2004

Re: Mark102 post# 26926

Friday, 04/17/2020 10:00:17 PM

Friday, April 17, 2020 10:00:17 PM

Post# of 35961
WOW HUGE! "Inspyr Therapeutics announced today that it has entered into an agreement with Ridgeway Therapeutics Inc. in which Ridgeway will license and assume control of certain assets relating to Inspyr’s oncology development programs, including intellectual property rights relating to adenosine antagonists owned by Inspyr."

https://www.prweb.com/releases/inspyr_to_license_oncology_related_compounds_to_ridgeway_therapeutics_inc/prweb15761201.htm